BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva expands scientific, digital, and training offering in China

The facility will host training for more than triple the current number of people per year. The upgraded Fast Trak center will support novel therapy dev...

September 18, 2023 | News

Porton Advanced and BRL Medicine Partner to Fast-Track Gene and Cell Therapy Commercialization

BRL Medicine, with its strong gene editing technology, robust R&D capabilities, and prospective pipelines, has been devoted to the realm of CGT for yea...

September 15, 2023 | News

Cure Genetics and Frametact Strike $60M Deal for Familial Neurological Disease Gene Therapy

The partnership will leverage Cure Genetics' proprietary VELP™ platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of fa...

September 15, 2023 | News

BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China

In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...

September 14, 2023 | News

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

"We are proud that through the DCS Lab Initiative, MGI technology and innovation will empower researchers and scientists in achieving their next breakthrou...

September 12, 2023 | News

Genesis MedTech Unveils China's First NPMA-Approved Antibacterial Sutures

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and...

September 12, 2023 | News

Mabwell and WuXi XDC Forge Long-Term ADC Partnership for Biologics Expansion

Mabwell has had multiple innovative products in clinical studies or preclinical research by their world-leading ADC technology platforms and CMC developmen...

September 11, 2023 | News

iotaSciences and Quantum Design China Enter into Distribution Agreement

iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Des...

September 07, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer

Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...

September 07, 2023 | News

IBT and ATLATL Join Forces to Tackle Challenges in Brain Health

Starting out of China, IBT Global is a rising player in Digital Therapeutics (DTx) with an experienced cross-functional team operating at the intersection ...

September 05, 2023 | News

China-Africa medical cooperation broadens under BRI

From there, he can admire the breathtaking views of the sleek, curved structure and the intricately layered sunshade components, showcasing the marvels of ...

September 04, 2023 | News

ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors

ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...

September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

Stay Connected